Filing Details

Accession Number:
0001209191-13-016170
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-13 12:31:04
Reporting Period:
2013-03-11
Filing Date:
2013-03-13
Accepted Time:
2013-03-13 12:31:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1396814 Pacira Pharmaceuticals Inc. PCRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1356950 Paul James Scopa C/O Mpm Asset Management
601 Gateway Blvd., Suite 350
South San Francisco CA 94080
No No No Yes
1358309 Mpm Bioventures Iv Qp Lp C/O Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
No No No Yes
1358311 Mpm Bioventures Iv Gp Llc C/O Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
No No No Yes
1358312 Mpm Bioventures Iv Llc C/O Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
No No No Yes
1358313 Mpm Asset Management Investors Bv4 Llc C/O Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
No No No Yes
1379218 John Vort Vander C/O Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
No No No Yes
1412336 Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg C/O Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
No No No Yes
1473930 Todd Foley C/O Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-03-11 500,000 $27.86 2,790,479 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
Footnotes
  1. The shares were sold as follows: 468,621 by MPM BioVentures IV-QP, L.P. ("BV IV QP"), 18,054 by MPM BioVentures IV GmbH & Co. Beteiligungs KG ("BV IV KG") and 13,325 by MPM Asset Management Investors BV4 LLC ("AM BV4"). MPM BioVentures IV GP LLC and MPM BioVentures IV LLC ("BV LLC") are the direct and indirect general partners of BV IV QP and BV IV KG and BV LLC is the manager of AM BV4. Vaughn M. Kailian, Ansbert Gadicke, Luke Evnin, James Paul Scopa, Todd Foley and John Vander Vort are the members of BV LLC.
  2. The shares are held as follows: 2,615,352 by BV IV QP, 100,758 by BV IV KG and 74,369 by AM BV4. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his, her or its respective pecuniary interest therein.